This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Allegra Medical Technologies Valuation

Is AMT undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of AMT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate AMT's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate AMT's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for AMT?

Key metric: As AMT is unprofitable and pre-revenue we use its Price-To-Book Ratio for relative valuation analysis.

The above table shows the Price to Book ratio for AMT. This is calculated by dividing AMT's market cap by their current book value.
What is AMT's PB Ratio?
PB Ratio	-2.2x
Book	-AU$1.61m
Market Cap	AU$3.47m

AMT key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	-8.5x
Enterprise Value/EBITDA	-2.8x
PEG Ratio	n/a

Price to Book Ratio vs Peers

How does AMT's PB Ratio compare to its peers?

The above table shows the PB ratio for AMT vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PB	Estimated Growth	Market Cap
Peer Average	3.6x
DVL dorsaVi	9.2x	n/a	AU$9.4m
AT1 Atomo Diagnostics	1.3x	n/a	AU$12.8m
CSX CleanSpace Holdings	1.5x	n/a	AU$29.1m
UCM Uscom	2.6x	n/a	AU$8.0m
AMT Allegra Medical Technologies	n/a	n/a	AU$3.5m

Price-To-Book vs Peers: AMT has negative equity and a Price-To-Book Ratio (-2.2x) compared to the peer average (2.7x).

Price to Book Ratio vs Industry

How does AMT's PB Ratio compare vs other companies in the AU Medical Equipment Industry?

3 Companies	Price / Book	Estimated Growth	Market Cap
OSP Osprey Medical	0.7x	n/a	US$3.57m
OVN Oventus Medical	0.6x	n/a	US$3.31m
VIP VIP Gloves	0.2x	n/a	US$1.56m

No more companies available in this PB range

3 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Book vs Industry: AMT has negative equity and a Price-To-Book Ratio (-2.2x) compared to the Australian Medical Equipment industry average (3.3x).

Price to Book Ratio vs Fair Ratio

What is AMT's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

AMT PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio	-2.2x
Fair PB Ratio	n/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate AMT's Price-To-Book Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Doctor Care Anywhere Group

AU$25.3m

Provides digital healthcare and development services in the United Kingdom, Australia, and the Republic of Ireland.

DOC

AU$0.07

4.5%

45.8%

CardieX

AU$32.4m

Engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific.

CDX

AU$0.11

-24.1%

n/a

Cogstate

AU$170.8m

A neuroscience technology company, engages in the creation, validation, and commercialization of digital brain health assessments used in both academic and industry sponsored research.

CGS

AU$0.99

4.2%

-35.5%